Qualitative and Quantitative Comparison of the Proteome of Erythroid Cells Differentiated from Human iPSCs and Adult Erythroid Cells by Multiplex TMT Labelling and NanoLC-MS/MS-Reference-Cited by-同舟云学术

Qualitative and Quantitative Comparison of the Proteome of Erythroid Cells Differentiated from Human iPSCs and Adult Erythroid Cells by Multiplex TMT Labelling and NanoLC-MS/MS

Published:2014-07-14 Issue:7 Volume:9 Page:e100874
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Trakarnsanga Kongtana,Wilson Marieangela C.,Griffiths Rebecca E.,Toye Ashley M.,Carpenter Lee,Heesom Kate J.,Parsons Steve F.,Anstee David J.,Frayne Jan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors;K Takahashi;Cell,2006

2. Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells;CJ Chang;PLoS One,2011

3. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin;J Hanna;Science,2007

4. Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universal-donor" red blood cells;A Seifinejad;Biochem Biophys Res Commun,2010

5. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases;L Ye;Proc Natl Acad Sci U S A,2009

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of immortalized bone marrow erythroid progenitor adult (imBMEP-A)—The first inducible immortalized red blood cell progenitor cell line derived from bone marrow CD71-positive cells;Cytotherapy;2024-07

2. Proteomics applications in next generation induced pluripotent stem cell models;Expert Review of Proteomics;2024-03-27

3. Optimization of seeding density of OP9 cells to improve hematopoietic differentiation efficiency;BMC Molecular and Cell Biology;2024-03-25

4. Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies;Nature Communications;2024-02-27

5. Cellular and animal models for the investigation of β-thalassemia;Blood Cells, Molecules, and Diseases;2024-01